Cardiomyopathy Trial, Recruiting (NCT06446271)

Cardiomyopathy Trial, Recruiting NCT06446271 Sponsor: NHS Greater Glasgow and Clyde Condition: Cardiomyopathy

Printed from Voxsanity (voxsanity.com.au) — NCT06446271 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Cardiomyopathy

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are aged 10 years or older (male or female)
You are able to provide written agreement to take part (or a parent/guardian can do so on your behalf if you are younger)
You have a known or likely harmful change (variant) in one of five specific heart muscle genes (TTN, LMNA, MYBPC3, DSP, or FLNC), OR you are in the process of being tested for one of these gene variants (if your test comes back negative, you may still be invited to join a comparison group)

Who may not be able to join:

You are not able to give your own consent to take part
You live too far away or have personal circumstances that would make it very difficult to travel to the study centre
You are not able to complete the tests and assessments required by the study
You have a serious non-heart-related illness that doctors expect may significantly shorten your life within the next 5 years
You are currently taking part in another clinical trial where neither you nor your doctor knows which treatment you are receiving, or you have taken such a treatment within the last 4 weeks

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 20 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 0141 451 6121

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06446271

Sponsor: NHS Greater Glasgow and Clyde

Phase: Not Applicable

Status: Recruiting

Condition: Cardiomyopathy

Trial contact: 0141 451 6121

More information: https://clinicaltrials.gov/study/NCT06446271

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are aged 10 years or older (male or female)
You are able to provide written agreement to take part (or a parent/guardian can do so on your behalf if you are younger)
You have a known or likely harmful change (variant) in one of five specific heart muscle genes (TTN, LMNA, MYBPC3, DSP, or FLNC), OR you are in the process of being tested for one of these gene variants (if your test comes back negative, you may still be invited to join a comparison group)

Who may not be able to join:

You are not able to give your own consent to take part
You live too far away or have personal circumstances that would make it very difficult to travel to the study centre
You are not able to complete the tests and assessments required by the study
You have a serious non-heart-related illness that doctors expect may significantly shorten your life within the next 5 years
You are currently taking part in another clinical trial where neither you nor your doctor knows which treatment you are receiving, or you have taken such a treatment within the last 4 weeks

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 20 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

NHS Greater Glasgow and Clyde

Registry

ClinicalTrials.gov

Start date

26 June 2024

Est. completion

19 March 2027

Where this trial is recruiting

🇬🇧 United Kingdom

Primary endpoints

Biomarker performance

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov